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We developed and tested a single multiplex polymerase
chain reaction (PCR) that detects enterotoxigenic, enteropatho-
genic, enteroinvasive, and Shiga toxin–producing Escherichia
coli. This PCR is specific, sensitive, and rapid in detecting tar-
get isolates in stool and food. Because of its simplicity, econ-
omy, and efficiency, this protocol warrants further evaluation in
large, prospective studies of polymicrobial substances. 
scherichia coli causes disease in humans through diverse
mechanisms (1). Classified on basis of their virulence
traits, the most well-studied members of the diarrheagenic E.
coli group include enterotoxigenic E. coli (ETEC), entero-
pathogenic  E. coli (EPEC), enteroinvasive E. coli (EIEC),
enteroaggregative E. coli (EAggEC), and Shiga-toxin–produc-
ing  E. coli (STEC), also called verocytotoxin-producing or
enterohemorrhagic  E. coli. ETEC produce secretory toxins
(enterotoxins); EPEC adhere intimately to epithelial cells and
induce host cell transmembrane signaling; EIEC invade
eukaryotic cells; and STEC produce Shiga toxins.
Identifying diarrheagenic  E. coli in the polymicrobial
milieus of stool and food poses challenges. Occasionally, eco-
nomically detectable phenotypes distinguish such organisms
when they are abundant in human stools. For example, sorbi-
tol- and lactose-nonfermenting colonies are typical of E. coli
O157:H7 and EIEC (2,3), respectively. However, these pheno-
types are nonspecific, and subsidiary testing is needed to con-
firm the isolate identity. In vitro assays that detect toxins,
adherence, or invasion phenotypes can also identify candidate
diarrheagenic E. coli. These determinations are often expen-
sive, require special expertise, and employ various detection
systems (e.g., cell culture, cytotoxicity assays). Applying such
assays to enteric microbiologic diagnosis is cumbersome.
Nucleic acid hybridization techniques, exploited by colony
hybridizations or polymerase chain reaction (PCR), apply a
single detection method to a diversity of organisms. The appli-
cation of nucleic acid amplifications requires selecting appro-
priate oligonucleotide primers and optimizing conditions to
maximize sensitivity and specificity. The inclusion of reac-
tions and conditions that apply to a variety of virulence loci so
that multiple candidate pathogens can be sought in a single
reaction makes this technology more efficient and economical.
Such multiplex detection is an appropriate solution to the chal-
lenge of finding diarrheagenic E. coli in stools and in food. We
describe the development of a multiplex PCR that detects four
categories of diarrheagenic E. coli and the application of the
assay to human diarrheal stools and food in Mexico City.
The Study
We developed a single multiplex PCR reaction to detect
ETEC, EPEC, EIEC, and STEC, using specific previously
described (4–6) or new primers (GIBCO-BRL, Gaithersburg,
MD) for diverse virulence traits (Table 1). Because primers for
loci that unambiguously distinguish pathogenic from non-
pathogenic EAggEC have not yet been determined (1), we did
not address this group in this study.
We prepared bacterial lysates by resuspending single colo-
nies in 1 mL of deionized water (Milli-Q System, Millipore,
Bedford, MA), boiling them 1 min, and then freezing them
until needed. E. coli O86:H18 was the negative control in all
assays. Each PCR tube contained 23 µL of reaction mix, com-
prised (in final concentrations) of Tris-HCl (10 mM, pH 8.3),
KCl  (50 mM), MgCl2  (2 mM), gelatin (100 µg/mL), glycerol
(5 % v/v), dATP, dCTP, dGTP, and dTTP (200 µM each),
AmpliTaq  polymerase (GIBCO-BRL) (0.5 U/23 µL), a mix-
ture of the 14 primers (Table 1), and 2 µL of bacterial lysates.
The final concentration of each primer in the reaction mix was
determined by employing a DNA mix (Table 1) of the four
prototype E. coli (7,10,11,13), until each of the seven PCR
products exhibited a band of similar intensity after electro-
phoresis in a 2.5% agarose gel in Tris-borate-EDTA buffer and
ethidium staining (Figure). The solutions were then subjected
to the following cycling conditions: 50°C (2 min, 1 cycle);
95°C (5 min, 1 cycle); 95°C, 50°C, and 72°C (45 sec each
temperature, 40 cycles); and a final extension step (10 min,
72°C) in a thermal cycler (iCycler System, Bio-Rad Laborato-
ries, Inc., Hercules, CA). PCR products (4 µL) were visualized
after electrophoresis and ethidium staining. The PCR sensitiv-
ity was determined by suspending one colony of each refer-
ence strain in individual 1-mL aliquots of sterile saline (0.85%
w/v). Serial twofold dilutions in sterile saline were then made
(to 1:256), and bacterial concentrations were determined by
plating on MacConkey agar. Each dilution was also subjected
to PCR analysis. E. coli 3030 (O86:H18) strain was used as a
negative control during the characterization.  In all further
experiments, the DNA mix from the four prototype E. coli
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served as the positive control. The multiplex PCR was further
characterized by using three additional reference strains for
each category (Table 1). 
Stools from 58 children <5 years of age hospitalized for
diarrhea in July, August, and September, 1999, at the three
main hospitals of the Instituto Mexicano del Seguro Social,
Mexico City, were studied. The Institutional Review Board of
the Institute approved this study, and parental informed con-
sent was obtained for each patient. Standard diagnostic evalua-
tions on these stools included culture for Campylobacter,
Salmonella, Shigella, Vibrio cholerae, Aeromonas, and Plesi-
omonas; identification of Rotavirus, Adenoviridae, Astrovirus,
and Caliciviridae by enzyme immunoassay; and microscopy
for  Entamoeba histolytica,  Cryptosporidium parvum,
Cyclospora cayetanensis, Isospora belli, and Giardia lamblia.
Five lactose-fermenting colonies and five sorbitol-nonfer-
menting colonies with morphology resembling that of E. coli
(when present) were selected from standard and sorbitol Mac-
Conkey agar plates, respectively, speciated biochemically, and
then subjected to multiplex PCR. 
Because of our concern about food safety, we purchased 52
food items (hot chili sauces and taco dressings) from street
vendors in Mexico City in July, August, and September, 1999,
and analyzed them for the presence of E. coli (which indicate
fecal contamination) and diarrheagenic E. coli, without enrich-
ment. One gram of food was added to 1 mL of 0.85% sterile
saline and vortexed, and serial 10-fold dilutions were pre-
pared. To enumerate candidate E. coli, and identify diarrhe-
agenic  E. coli, 100 µL of each sample and dilutions were
plated on MacConkey and sorbitol MacConkey agar plates.
Five pink colonies from MacConkey and five colorless colo-
nies from sorbitol MacConkey agar were tested for indole pos-
itivity and the lactose-fermenting phenotype (if selected from
the sorbitol plate). Only indole-positive, lactose-fermenting
Table 1. Prototypes and reference strains of ETEC, EPEC, EIEC, and STEC tested in the multiplex PCR by using specific oligonucleotide primers 
for several locia 
E. coli category tested 
strains and serotypes Locus Primers 
Amplicon
size (bp)
Primer (pMol) 
in mix
ETEC 
H10407  O78:H11b (7)
E9034A  O8:H9 (8)
B2C    O6:H16 (8)
E8775A  O25:H42c (9)
lt F:5´GGC GAC AGA TTA TAC CGT GC3´(4)
R:5´ CGG TCT CTA TAT TCC CTG TT3´(4)
450 5.0
ETEC 
H10407  O78:H11b (7)
E9034A  O8:H9 (8)
B2C    O6:H16 (8)
E8775A  O25:H42c (9)
st F:5´ATT TTT CTT TCT GTA TTG TCT T3´(4)
R:5´CAC CCG GTA CAA GCA GGA TT3´(4)
190 6.47
EPEC 
E2348-69 O127:H6b (10)
B171-8  O111:NM (10)
659-79  O119:H6 (10)
E851/71  O142:H6 (10) 
bfpA F:5´AAT GGT GCT TGC GCT TGC TGC3´ (5)
R:5´ GCC GCT TTA TCC AAC CTG GTA3´ (5)
324 2.5
EPEC 
E2348-69 O127:H6b (10)
B171-8  O111:NM (10)
659-79  O119:H6 (10)
E851/71  O142:H6 (10)
STEC 
EDL933 O157:H7b (11)
TB334C O85:NM (12)
TB285A O126:H2 (12)
TB226A O11:HN(12)
eaeA F:5´ GAC CCG GCA CAA GCA TAA GC3´ (6)
R:5´CCA CCT GCA GCA ACA AGA GG3´ (6)
384 3.88
STEC 
EDL933 O157:H7b (11)
TB334C O85:NM (12)
TB285A O126:H2 (12)
TB226A O11:HN (12)
stx1 F:5´CTG GAT TTA ATG TCG CAT AGT G3´d 
(GenBank accession no. M17358)
R:5´AGA ACG CCC ACT GAG ATC ATC3´ (6)
150 3.88
STEC
EDL933 O157:H7b  (11)
TB226A O11:HN (12)
stx2 F:5´GGC ACT GTC TGA AAC TGC TCC3´ (6)
R:5´TCG CCA GTT ATC TGA CAT TCT G3´ (6)
255 2.5
EIEC 
E11 O124NMb  (13)
O124:H30 (14) 
O136:NM (14) 
O143:NM (14) 
ial F:5´GGT ATG ATG ATG ATG AGT CCA 3´ d
(GenBank accession no. D13663)
R:5´ GGA GGC CAA CAA TTA TTT CC 3´d
650 10.25
aE. coli, Escherichia coli; ETEC, enterotoxigenic E. coli; EPEC, enteropathogenic E. coli; EIEC, enteroinvasive E. coli; STEC, Shiga-toxin–producing E. coli; PCR, polymerase chain 
reaction.
bE. coli prototype strains. 
cDonated by the Public Health Laboratory Service, Central Health Laboratory, London, United Kingdom.
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colonies isolated from both media were then subjected to the
multiplex PCR. STEC from patients and food were tested to
determine if they expressed the O157 lipopolysaccharide anti-
gen by using latex particle agglutination (Oxoid Limited, Bas-
ingstoke, UK). 
Multiplex PCR detected the appropriate loci in each posi-
tive control strain; extraneous bands were not produced (Fig-
ure). When DNA from each of the four reference strains was
mixed, the same bands appeared without nonspecific amplifi-
cation (Figure). The minimum number of CFU detected were
320–1,526 for ETEC; 84–168 for EPEC; 120–1,556 for EIEC;
and 20–194 for E. coli O157:H7. 
Eleven (19%) of the 58 patients had candidate diarrhe-
agenic E. coli in their stools (Table 2). In 6 (55%) of these 11
patients, no other enteric pathogens was identified, and in 3
patients target sequences were found in each of the selected E.
coli colonies (Table 2). Thus, these candidate pathogens con-
stituted the predominant aerobic coliform flora in some sam-
ples. None of the other 47 patients with diarrhea had E. coli
containing the target loci in their stools. Twenty-two (42%) of
the 52 food samples contained E. coli, and 7 (13%) contained
candidate diarrheagenic E. coli (Table 2). No STEC isolated
from patients or food expressed the O157 LPS antigen, and
most were eae negative.
Conclusions
This multiplex PCR specifically and sensitively detected a
diversity of loci in E. coli with ease, speed, and economy; its
utility was demonstrated by using reference strains as well as
clinical and food isolates. Conceivably, additional loci might
Figure. Polymerase chain reaction (PCR) products of each locus. Lane
1: sizes of the seven PCR products of each locus in base pairs,
obtained when using a DNA mix of the four reference strains and the
primers mix. PCR products obtained by using DNA of enterotoxigenic
Escherichia coli, Shiga-toxin–producing E. coli, enteropathogenic E.
coli, and enteroinvasive E. coli (lanes 2–5, respectively). Lane 6–11:
PCR products obtained when using DNA of patients’ isolates and the
primers mix. Lanes 12–15: PCR products obtained when using DNA of
food isolates and the primers mix. Lane 16: 1 kb molecular weight
marker in base pairs.
Table 2. Diarrheagenic Escherichia coli isolates in patient and food samplesa
Samples Diarrheagenic E. coli group Identified genes No. positive strains/ no. tested Other pathogens isolated CFU/gram food
Stool
Patient 1 STEC stx1,eae A 5/5 none
Patient 2 STEC stx2 5/5 none
Patient 3 ETEC lt 2/5 none
Patient 4 STEC stx 2 2/9 none
Patient 5 STEC stx 2 1/5 none
Patient 6 EIEC ial 1/5 none
Patient 7 ETEC lt 5/5 Shigella  flexneri
Patient 8 ETEC st 2/5 S. sonnei
Patient 9 EPEC bfpA, eaeA1 / 5 S. sonnei
Patient 10 ETEC lt 1/5 Rotavirus, S. sonnei
Patient 11 STEC stx1, eae A 1/10 Rotavirus
Food
Green sauce ETEC lt, st 5/5 8.0 x 102
Green sauce ETEC lt, st 5/5 1.3 x 105
Raw cabbage STEC stx1, stx2 2/5 2.6 x 105
Green sauce ETEC st 1/5 2.6 x 104
Green sauce EIEC ial 1/5 6.0 x 102
Raw coriander EIEC ial 1/5 1.8 x 105
Raw lettuce EIEC ial 1/5 8.2 x 104
aSTEC, Shiga-toxin–producing Escherichia coli; ETEC, enterotoxigenic E. coli; EIEC, enteroinvasive E. coli; EPEC, enteropathogenic E. coli.DISPATCHES
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be included because no signal attenuation occurred when a
mixture of reference strains was assayed. The estimated cost
per reaction for one strain is U.S. $2.00, compared to U.S.
$15.00 for a colony blot analysis for one strain (data not
shown). Furthermore, the signals from colony hybridizations
are sometimes equivocal, in contrast to the unambiguous data
obtained from our assay. 
We believe that multiplex nucleic acid amplification to
detect a panel of putatively pathogen traits should be consid-
ered as a replacement for tedious, less sensitive, and less spe-
cific detection technologies in clinical and food microbiologic
analyses. This method should also be considered to be a more
parsimonious use of PCR reagents than the individual locus
PCR testing protocols described by others (15,16). Moreover,
our approach does not rely on DNA extraction (16); boiling of
cultures provides adequate nucleic acid to detect sequences of
interest. 
Comparing our protocol’s sensitivity to that reported in
other protocols is difficult because of differences in methods.
Specifically, other techniques seek amplicons directly from
stool cultures (17) or employ fecal DNA extraction (4),
whereas we assessed isolated, randomly picked colonies. Nev-
ertheless, our sensitivity ranges were within the range of previ-
ous reports (18,19), to the extent that we were able to compare
them. Our approach also provides, simultaneously, an indica-
tion of the proportion of fecal gram-negative organisms that
contain loci of interest. 
Without a more extensive epidemiologic analysis, we can-
not state with certainty that the positive E. coli isolated were
the causes of the diarrhea in the children studied. However, in
some samples, the PCR-positive organisms were well repre-
sented among the aerobic coliform flora selected for analysis.
Such organisms were also well represented among the food
isolates. Because these E. coli indicate fecal contamination,
our findings present a disconcerting picture of the hygienic
status of street-vended food in Mexico City. In fact, our colony
selection protocol was biased towards high-frequency organ-
isms because we sampled only five such strains. Surveys that
examine several hundred colonies (20) or PCR amplification
of supernatant of fecal or food outgrowths (17,21) or of
extracted DNA (4) could detect target organisms at lower den-
sities. Though the clinical and food safety implications of low
levels of candidate diarrheagenic E. coli remain unclear, multi-
ple studies have demonstrated that consumption of food sold
by street vendors is a risk factor for acquiring diarrhea in Mex-
ico (22–24) and elsewhere (25–27), and attempts to improve
the safety of these ubiquitous vehicles would most likely
improve public health.
We have demonstrated for the first time that multiplex
PCR can detect a variety of diarrheagenic E. coli with relative
ease. Such organisms are found in food vended in Mexico City
and in local children with diarrhea. This feasible technology
should be evaluated in larger, controlled, prospective studies
of human diarrhea and in microbiologic studies of food to
establish the current epidemiology of these pathogens, includ-
ing the emerging strains of STEC.
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